Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers

Cancer

Volumn 116, Issue SUPPL. 11, 2010, Pages 2768-2782

  Wu, Mei ^a   Wu, Zhi Fen ^a   Rosenthal, Devin T ^a   Rhee, Elliot M ^a   Merajver, Sofia D ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Adhesion; Invasion; Motility; RHOA; RHOC

Indexed keywords

ALPHA2 INTEGRIN; BETA1 INTEGRIN; COLLAGEN TYPE 1; GUANINE NUCLEOTIDE BINDING PROTEIN; MATRIGEL; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC GUANINE NUCLEOTIDE BINDING PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; GUANOSINE TRIPHOSPHATASE; MESSENGER RNA; RHOC PROTEIN;

BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MOTILITY; CELL STRAIN; CELL STRAIN MDA MB 231; CELL STRAIN SUM 149; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATORY BREAST CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RNA INTERFERENCE; STRESS FIBER; WESTERN BLOTTING; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; MOLECULAR DYNAMICS; PHENOTYPIC VARIATION; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN GENE; RHOC GENE; STABLE EXPRESSION; TUMOR GENE;

BREAST NEOPLASMS; CELL MOVEMENT; CLONE CELLS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFLAMMATION; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM INVASIVENESS; RHO GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING;

EID: 77952709202     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25181     Document Type: Conference Paper

References (56)

1. Wheeler AP, Ridley AJ. Why 3 Rho proteins? RHOA, RhoB, RHOC, and cell motility. Exp Cell Res. 2004;301:43-49.
2. Sahai E, Marshall CJ. Rho-GTPases and cancer. Nat Rev Cancer. 2002;2:133-142.
3. Burbelo P, Wellstein A, Pestell RG. Altered Rho GTPase signaling pathways in breast cancer cells. Breast Cancer Res Treat. 2004;84:43-48. (Pubitemid 38388859)
4. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RHOC. Nature. 2000;406:532-535.
5. Horiuchi A, Imai T, Wang C, et al. Up-regulation of small GTPases, RHOA and RHOC, is associated with tumor progression in ovarian carcinoma. Lab Invest. 2003;83:861-870. (Pubitemid 36723695)
6. Suwa H, Ohshio G, Imamura T, et al. Overexpression of the RHOC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer. 1998;77:147-152.
7. Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD. Characterization of RHOC expression in benign and malignant breast disease - a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol. 2002;160:579-584. (Pubitemid 34160335)
8. Kleer CG, Griffith KA, Sabel MS, et al. RHOC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Res Treat. 2005;93: 101-110.
9. van Golen KL, Davies S, Wu ZF, et al. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RHOC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res. 1999;5:2511-2519.
10. Wang W, Yang LY, Huang GW, et al. Genomic analysis reveals RHOC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer. 2004;90:2349-2355. (Pubitemid 38961899)
11. van Golen K, Wu ZF, Qiao XT, Bao LW, Merajver SD. RHOC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res. 2000; 60:5832-5838.
12. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629-635.
13. DeMali KA, Wennerberg K, Burridge K. Integrin signaling to the actin cytoskeleton. Curr Opin in Cell Biol. 2003;15: 572-582.
14. Defilippi P, Olivo C, Venturino M, Dolce L, Silengo L, Tarone G. Actin cytoskeleton organization in response to integrin-mediated adhesion. Microsc Res Tech. 1999;47:67-78. (Pubitemid 29474836)
15. Streuli CH, Edwards GM. Control of normal mammary epithelial phenotype by integrins. J Mammary Gland Biol Neoplasia. 1998;3:151-163.
16. Zhou H, Kramer RH. Integrin engagement differentially modulates epithelial cell motility by RHOA/ROCK and PAK1. J Biol Chem. 2005;280:10624-10635. (Pubitemid 40395924)
17. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004;5:816-826.
18. Dedhar S. Integrins and tumor invasion. Bioessays. 1990;12: 583-590.
19. Albelda SM. Biology of disease. Role of integrins and other adhesion molecules in tumor progression and metastasis. Lab Invest. 1993;68:4-17.
20. Juliano R. Signal transduction by integrins and its role in the regulation of tumor growth. Cancer Metastasis Rev. 1994;13:25-30. (Pubitemid 24053337)
21. Zutter MM, Sun H, Santoro SA. Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors. J Mammary Gland Biol Neoplasia. 1998;3:191-200. (Pubitemid 128513230)
22. Taddei I, Faraldo MM, Teuliere J, Deugnier M-A, Thiery JP, Glukhova MA. Integrins in mammary gland development and differentiation of mammary epithelium. J Mammary Gland Biol Neoplasia. 2003;8:383-394. (Pubitemid 39137501)
23. Zutter MM, Santoro SA, Staatz WD, Tsung YL. Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA. 1995;92:7411-7415.
24. Keely P, Fong AM, Zutter MM, Santoro SA. Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense alpha 2 integrin mRNA in mammary cells. J Cell Sci. 1995;108:595-607.
25. Chan BMC, Matsuura N, Takada Y, Zetter BR, Hemler ME. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science. 1991;251:1600-1602.
26. Santala P, Larjava H, Nissinen L, Riikonen T, Maata A, Heino J. Suppressed collagen gene expression and induction of alpha 2 beta 1 integrin-type collagen receptor in tumorigenic derivatives of human osteogenic sarcoma (HOS) cell line. J Biol Chem. 1994;269:1276-1283.
27. Eguchi H, Horikoshi T. The expression of integrin alpha 2 beta 1 and attachment to type I collagen of melanoma cells are preferentially induced by tumour promoter, TPA (12-O-tetradecanoyl phorbol-13-acetate). Br J Dermatol. 1996;134: 33-39.
28. Nissinen L, Westermarck J, Koivisto L, Kahari VM, Heino J. Transcription of alpha 2 integrin gene in osteosarcoma cells is enhanced by tumor promoters. Exp Cell Res. 1998; 243:1-10.
29. Faraldo MM, Deugnier M-A, Lukashev M, Thiery JP, Glukhova MA. Perturbation of beta1-integrin function alters the development of murine mammary gland. EMBO J. 1998;17:2139-2147.
30. Li N, Zhang Y, Naylor MJ, et al. Beta1 integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoli. EMBO J. 2005;24:1942-1953.
31. White DE, Kurpios NA, Zuo D, et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell. 2004;6:159-170.
32. Brakebusch C, Wennerberg K, Krell HW, et al. Beta1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts. Oncogene. 1999;18:3852-3861. (Pubitemid 29358563)
33. Brockbank EC, Bridges J, Marshall CJ, Sahai E. Integrin beta1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo. Br J Cancer. 2005;92:102-112. (Pubitemid 40188442)
34. Raghavan S, Vaezi A, Fuchs E. A role for alphabeta1 integrins in focal adhesion function and polarized cytoskeletal dynamics. Dev Cell. 2003;5:415-427. (Pubitemid 37107671)
35. Wu M, Wu ZF, Kumar-Sinha C, Chinnaiyan A, Merajver SD. RHOC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells. Breast Cancer Res Treat. 2004;84:3-12. (Pubitemid 38388855)
36. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer. 2002;87:635-644.
37. Kreis T, Vale R. Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins. 2nd ed. New York: Sambrook & Tooze Publication at Oxford University Press; 1999.
38. Nakano K, Takaishi K, Kodama A, et al. Distinct actions and cooperative roles of ROCK and mDia in Rho small G protein-induced reorganization of the actin cytoskeleton in Madin-Darby canine kidney cells. Mol Biol Cell. 1999; 10:2481-2491. (Pubitemid 29393504)
39. Madaule P, Furuyashiki T, Reid T, et al. Citron, a novel partner for the GTP-bound forms of rho and rac. FEBS Letters. 1995;377:243-248. (Pubitemid 26015076)
40. Sahai E, Marshall CJ. ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat Cell Biol. 2002;4:408-415.
41. Maekawa M, Ishizaki T, Boku S, et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 1999;285:895-898.
42. Kamai T, Tsujii T, Arai K, et al. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res. 2003;9:2632-2641.
43. Worthylake RA, Burridge K. RHOA and ROCK promote migration by limiting membrane protrusions. J Biol Chem. 2003;278:13578-13584.
44. Hakem A, Sanchez-Sweatman O, You-Ten A, et al. RHOC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev. 2005;19:1974-1979. (Pubitemid 41247955)
45. Pille JY, Denoyelle C, Varet J, et al. Anti-RHOA and anti-RHOC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther. 2005;11:267-274.
46. Simpson KJ, Dugan AS, Mercurio AM. Functional analysis of the contribution of RHOA and RHOC GTPases to invasive breast carcinoma. Cancer Res. 2004;64:8694-8701.
47. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer. 2002;2:91-100. (Pubitemid 37328796)
48. Hall CL, Dai J, van Golen KL, Keller ET, Long MW. Type I collagen receptor (a2b1) signaling promotes the growth of human prostate cancer cells within the bone. Cancer Res. 2006;66:8648-8654.
49. Hall CL, Dubyk CW, Riesenberger TA, Shein D, Keller ET, van Golen KL. Type I collagen receptor (α2β1) signaling promotes prostate cancer invasion through RHOC GTPase. Neoplasia. 2008;10:797-803.
50. Giancotti FG, Tarone G. Positional control of cell fate through joint integrin-receptor protein kinase signaling. Annu Rev Cell Dev Biol. 2003;19:173.
51. Vial E, Sahai E, Marshall CJ. ERK-MAPK signaling coordinately regulates activity of Rac1 and RHOA for tumor cell motility. Cancer Cell. 2003;4:67-79. (Pubitemid 36904162)
52. Chen JC, Zhuang S, Nguyen TH, Boss GR, Pilz RB. Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity. J Biol Chem. 2003; 278:2807-2818. (Pubitemid 36801183)
53. Sahai E, Olson MF, Marshall CJ. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 2001;20:755-766. (Pubitemid 32167640)
54. Keely PJ, Rusyn EV, Cox AD, Parise LV. R-Ras signals through specific integrin a cytoplasmic domains to promote migration and invasion of breast epithelial cells. J Cell Biol. 1999;145:1077.
55. Maschler S, Wirl G, Spring H, et al. Tumor cell invasiveness correlates with changes in integrin expression and localization. Oncogene. 2005;24:2032-2041. (Pubitemid 40516196)
56. van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. Mitogen activated protein kinase pathway is involved in RHOC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin Exp Metastasis. 2002;19:301-311 (Pubitemid 34606755)